Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

NCT04519905 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04519905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Recruiting
Start date
January 6, 2020
Completion date
December 31, 2027
Enrollment
320 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiotherapy, esophageal squamous cell carcinoma, survival